Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) General Information

Description

A patent right for nucleic acid molecules inducing RNA interference located in Suwon, South Korea.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Suwon
  • South Korea
Primary Industry
Buildings and Property
Corporate Office
  • Suwon
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)‘s full profile, request access.

Request a free trial

Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)‘s full profile, request access.

Request a free trial

Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) FAQs

  • Where is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) headquartered?

    Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is headquartered in Suwon, South Korea.

  • What industry is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) in?

    Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)’s primary industry is Buildings and Property.

  • Is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) a private or public company?

    Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is a Private company.

  • What is the current valuation of Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)?

    The current valuation of Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is .

  • What is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)’s current revenue?

    The current revenue for Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is .

  • Who are Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)’s investors?

    Sungkyunkwan University has invested in Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference).

  • When was Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) acquired?

    Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) was acquired on 30-Aug-2018.

  • Who acquired Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)?

    Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) was acquired by Olix Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process